Guangzhou Da'an Gene Co., Ltd. is a state-owned biopharmaceutical high-tech enterprise that focuses on molecular diagnostic technology and integrates independent research and development,production, and sales of clinical testing reagents, instruments, and supporting consumables. As one of the first high-tech enterprises for in vitro diagnostics in China, the company was listed on the Shenzhen Stock Exchange in 2004 (stock code: SZ002030). After years of independent innovation breakthroughs and stable business accumulation, it has been selected as a national intellectual property demonstration enterprise multiple times, and its independently developed products have been awarded titles such as "National Key New Product" and "Guangdong Province Key New Product". At present, we have achieved horizontal and vertical coverage of the entire PCR industry chain, including research and development production, core raw materials, quality control products, instrument research and development production, and testing services. Our products serve more than 140 countries and regions nationwide and worldwide.

As a leading enterprise in the industry, Da'an Gene was selected as the main enterprise in the "Medical and Health" industry chain and the main unit in the "Medical Inspection and Testing Chain" among the 21 key industry chains in Guangzhou in 2021. Through the "main business+incubation" strategy of strengthening the main business and refining incubation, Daan Gene provides resources and services for small and medium-sized enterprises in the field of big health, from research and development projects to enterprise listing. Focusing on the upstream and downstream of in vitro diagnostics and key core technologies, it promotes the integration and development of the entire industry chain through industrial investment, empowers the ecosystem, and helps upgrade the industry chain. Currently, it has incubated nearly 300 biopharmaceutical enterprises with independent innovation capabilities. The company is firmly rooted in the belief that "innovation is the first driving force for development", guided by ensuring people's health and promoting the construction of a healthy China, adhering to the principle of quality first, and driving the high-quality development of the company through product strength, expansion, organizational strength, and cultural strength - the "four forces".